Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures

Experimental Neurology

Volumn 142, Issue 2, 1996, Pages 340-350

  Østergaard, Karen ^c   Jones, S Angharad ^a   Hyman, Carolyn ^b   Zimmer, Jens ^c  

^a OX1 3QT   (United Kingdom)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; NEWBORN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

EID: 2142704230     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0203     Document Type: Article

References (54)

1. 1. AGID, Y. 1995. Aging, disease and nerve cell death. Bull. Acad. Natl. Med. (Paris) 179: 1193-1207.
2. 2. APPEL, S. H. 1981. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer Disease. Ann. Neurol. 10: 499-505.
3. 3. ALTAR, A. C., C. B. BOYLAN, C. JACKSON, S. HERSHENSONET, J. MILLER, S. J. WIEGAND, R. M. LINDSAY, AND C. HYMAN. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 89: 11347-11351.
4. 4. BECK, K. D., B. KNÜSEL, AND F. HEFTI. 1993. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulun-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52: 855-866.
5. 5. BECK, K. D., J. VALVERDE, T. ALEXI, K. POULSEN, B. MOFFAT, R. A. VANDLEN, A. ROSENTHAL, A, F. HEFTI. 1995. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341.
6. 6. COTMAN, C. W., AND A. J. ANDERSON. 1995. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10: 19-45.
7. 7. DAGUET, M. C., U. DIPORZIO, A. PROCHIANTZ, A. KATO, J. GLOWINSKI. 1980. Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in abscence or presence of striatal target cells. Dev. Brain. Res. 191: 564-568.
8. 8. DAL TOSO, R., O. GIORGI, C. SORANZO, G. KIRSCHNER, G. FERRARI, M. FAVARON, D. BENVEGNÙ, D. PRESTI, S. VICINI, G. TOFFANO, G. F. AZZONE, AND A. LEON. 1988. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: I. Effects of cell density and of an adult mammalian striatal-derived neuronotrophic factor (SDNF). J. Neurosci. 8: 733-737.
9. 9. DAVIES, A. M. 1994. Switching neurotrophin dependence. Curr. Biol. 4: 273-276.
10. 10. DIPRRZIO, U., M. C. DAGUET, J. GLOWINSKI, A. PROCHIANTZ. 1980. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288: 370-373.
11. 11. DISTEFANO, P. S., B. FRIEDMAN, C. RADZIEJEWSKI, C. ALEXANDER, P. BOLAND, C. M. SCHICK, R. M. LINDSAY, AND S. J. WIEGAND. 1992. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8: 983-993.
12. 12. DU, X., N. D. STULL, L. IACOVITTI. 1995. Brain-derived neurotrophic factor works coordinately with partner molecule to initiate tyrosine hydroxylase expression in striatal neurons. Brain Res. 680: 229-233.
13. 13. FADDA, E., A. NEGRO, L. FACCI, AND S. D. SKAPER. 1993. Ganglioside GM1 cooperates with brain-derived neurotrophic factor to protect dopaminergic neurons from 6-hydroxydopamine-induced degeneration. Neurosci. Lett. 159: 147-150.
14. 14. FRIEDMAN, W. J., L. OLSON, AND H. PERSSON. 1991. Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain. Eur. J. Neurosci. 3: 688-697.
15. 15. FRIM, D. M., T. A. UHLER, M. P. SHORT, Z. D. EZZEDINE, M. KLAGSBRUN, X. O. BREAKEFIELD, AND O. ISACSON. 1993. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. NeuroReport 4: 367-370.
16. 16. GALL, C. M., S. J. GOLD, P. J. ISACKSON, AND K. B. SEROOGY. 1992. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol. Cell. Neurosci. 3: 56-63.
17. 17. GERPEN, C. R., M. HERKENHAM, AND J. THIBAULT. 1987. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7: 3915-3934.
18. 18. GERFEN, C. R., K. G. BAIMBRIDGE, AND J. THIBAULT. 1987. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 7: 3935-3944.
19. 19. HANAWAY, J., J. A. MCCONNELL, AND M. G. NETSKY. 1971. Histogenesis of the substantia nigra, ventral tegmental area of Tsai and interpeduncular nucleus: an autoradiographic study of the mesencephalon in the rat. J. Comp. Neurol. 142: 59-74.
20. 20. HEFTI, F., J. HARTIKKA, AND B. KNUSEL. 1989. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging 10: 515-533.
21. 21. HEMMENDINGER, L. M., B. B. GARBER, P. C. HOFFMAN, AND A. HELLER. 1981. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc. Natl. Acad. Sci. USA 78: 1264-1268.
22. 22. HYMAN, C., M. HOFER, Y.-A. BARDE, M. JUHASZ, G. D. YANCOPOULOS, S. P. SQUINTO, AND R. M. LINDSAY. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232.
23. 23. HYMAN, C., M. JUHASZ, C. JACKSON, P. WRIGHT, N. Y. IP, AND R. M. LINDSAY. 1994. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and Gabaergic neurons of the ventral mesencephalon. J. Neurosci. 14: 335-347.
24. 24. KLEIN, R., V. NANDURI, S. JING, F. LAMBALLE, P. TAPLEY, S. BRYANT, C. CORDON-CARDO, K. R. JONES, L. F. REICHARDT, AND M. BARBACID. 1991. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66: 395-403.
25. 25. KNÜSEL, B., J. W. WINSLOW, A. ROSENTHAL, L. E. BURTON, D. P. SEID, K. NIKOLICS, AND F. HEFTI. 1991. Promotion of central cholinergic and dopaminergic neuron differentation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA 88: 961-965.
26. 26. KNÜSEL, B., K. D. BECK, J. W. WINSLOW, A. ROSENTHAL, L. E. BURTON, H. R. WIDMER, K. NICOLICS, AND F. HEFTI. 1992. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12: 4391-4402.
27. 27. KOKAIA, Z., J. BENGZON, M. METSIS, M. KOKAIA, H. PERSSON, AND O. LINDVALL. 1993. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc. Natl. Acad. Sci. USA 90: 6711-6715.
28. 28. LAPCHAK, P. A., K. D. BECK, D. M. ARAUJO, I. IRWIN, J. W. LANGSTON, AND F. HEFTI. 1993. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53: 639-650.
29. 29. LEIBROCK, J., F. LOTTSPEICH, A. HOHN, M. HOFER, B. HENGERER, P. MASAIAKOWSKI, H. THOENEN, AND Y-A. BARDE. 1989. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341: 149-152.
30. 30. LIN, L.-F. H., D. H. DOHERTY, J. D. LILE, S. BEKTESH, AND F. COLLINS. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
31. 31. LINDSAY, R. M., C. A. ALTAR, J. M. CEDARBAUM, C. HYMAN, AND S. J. WIEGAND. 1993. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol. 124: 103-118.
32. 32. LINDSAY, R. M., S. J. WIEGAND, C. A. ALTAR, AND P. S. DISTEFANO. 1994. Neurotrophic factors: from molecule to man. Trends Neurosci. 17: 182-190.
33. 33. LINDSAY, R. M. 1995. Neuron saving schemes. Nature 373: 289-290.
34. 34. MASAIAKOWSKI, P., H. LIU, C. RADZIEJEWSKI, F. LOTTSPEICH, W. OBERTHUER, V. WONG, R. M. LINDSAY, M. E. FURTH, AND N. PANAYOTATOS. 1991. Recombinant human and rat ciliary neurotrophic factors. J. Neurochem. 57: 1003-1012.
35. 35. MEAKIN, S. O., AND E. M. SHOOTER. 1992. The nerve growth factor family of receptors. Trends Neurosci. 15: 323-331.
36. 36. OO, T. F., AND R. E. BURKE. 1996. Time course of developmental cell death in phenotypically-defined dopaminergic neurons of the substantia nigra. Symposium on mesencephalic dopaminergic cell cultures, NIH 1996. Abstracts: P19.
37. 37. ØSTERGAARD, K., J. P. SCHOU, J. ZIMMER. 1990. Rat ventral mesencephalon grown as organotypic slice cultures and cocultured with striatum, hippocampus, and cerebellum. Exp. Brain. Res. 82: 547-565.
38. 38. ØSTERGAARD, K., J. P. SCHOU, B. H. GÄHWILER, J. ZIMMER. 1991. Tyrosine hydroxylase immunoreactive neurons in organotypic slice cultures of the rat striatum and neocortex. Exp. Brain Res. 83: 357-365.
39. 39. ØSTERGAARD, K. 1993. Organotypic slice cultures of the rat striatum. I. A histochemical and immunocytochemical study of acetylcholinesterase, choline acetyltransferase, glutamate decarboxylase and GABA. Neuroscience 53: 679-693.
40. 40. ØSTERGAARD, K., B. FINSEN, AND J. ZIMMER. 1995. Organotypic slice cultures of the rat striatum: an immunocytochemical, histochemical and in situ hybridization study of somatostatin, neuropeptide Y, nicotinamide adenine dinucleotide phosphatediaphorase, and enkephalin. Exp. Brain Res. 103: 70-84.
41. 41. PROCHIANTZ, A., U. DIPORZIO, A. KATO, B. BERGER, AND J. GLOWINSKI. 1979. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc. Natl. Acad. Sci. USA 76: 5387-5391.
42. 42. RAFF, M. C., B. A. BARRES, J. F. BURNE, H. S. COLES, Y. ISHIZAKI, AND M. D. JACOBSON. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262: 695-700.
43. 43. REYNOLDS, B. A., AND S. WEISS. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
44. 44. SAUER, H., W. FISCHER, G. NIKKHAH, S. J. WIEGAND, P. BRUNDIN, R. M. LINDSAY, AND A. BJÖRKLUND. 1993. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626: 37-44.
45. 45. SEROOGY, K. B., K. H. LUNDGREN, T. M. D. TRAN, K. M. GUTHRIE, P. J. ISACKSON, AND C. M. GALL. 1994. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342: 321-334.
46. 46. SPECHT, L. A., V. M. PICKEL, T. H. JOH, AND D. J. REIS. 1981. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny. J. Comp. Neurol. 199: 233-253.
47. 47. SPINA, M. B., S. P. SQUINTO, J. MILLER, R. M. LINDSAY, AND C. HYMAN. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59: 99-106.
48. 48. STELLER, H. 1995. Mechanisms and genes of cellular suicide. Science. 267: 1445-1449.
49. 49. STRÖMBERG, I., L. BJÖRKLUND, M. JOHANSSON, A. TOMAC, F. COLLINS, L. OLSON, B. HOFFER, AND C. HUMPEL. 1993. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124: 401-412.
50. 50. TOMAC, A., J. WIDENFALK, L.-F. H. LIN, T. KOHNO, T. EBENDAL, B. J. HOFFER, L. OLSON. 1995. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92: 8274-8278.
51. 51. THOMPSON, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267: 1456-1462.
52. 52. VANTINI, G., AND S. D. SKAPER. 1992. Neurotrophic factors: From physiology to pharmacology? Pharmacol. Res. 26: 1-15.
53. 53. VOORN, P., A. KALSBEEK, B. JORRITSMA-BYHAM, AND H. J. GROENEWEGEN. 1988. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25: 857-887.
54. 54. ZHOU, J., H. F. BRADFORD, AND G. M. STERN. 1994. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res. 656: 147-156.